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The inability of the oil supply to meet the world demand fosters the need for research on environmentally-friendly production of biofuels. Yeast are the logical option rather than prokaryotes due to 
their tolerance to pH and robustness against inhibition and toxic compounds. Metabolic engineering and synthetic biology tools are proving crucial in the design of biofuel-producing microorganisms 
with high yields from raw material. In fact, important companies are filing patents with their advances in the race for such microbial cell factory. This work reviews the most relevant advances in the 
field at laboratory scale, describing the importance of the techniques used and the current limitations of industrial-scale production. 
Although production of bioethanol is by far the most advanced of all biofuels, isobutanol is 
promising likewise due to its many advantages, including [1]: 
o Higher energy density 
o Reduced distribution costs 
o Less hygroscopy and corrosiveness 
o Easier storage and transportation 
o Adaptability to existing distribution networks 
These characteristics make isobutanol an attractive and promising alternative, encouraging 
worldwide research on its synthesis. 
Isobutanol is produced normally in S. cerevisiae as part of the valine metabolism in the so-called 
Ehrlich pathway, the steps of which are split between cytosol and mitochondria. This pathway 
is the basis for research on isobutanol production enhancement. 
Introduction 
Why isobutanol? 
Isobutanol synthesis: 
the Ehrlich pathway 
Final [isobutanol] 
(mg/L) 
Productivity 
(mg/L·h) 
Isobutanol/glucose 
yield (mg/g) 
1 
Pathway 
engineering only 
143 1.2 6.6 
2 
Cytosolic 
re-localization 
630 6.6 14.86 
3 
Mitochondrial 
re-localization 
635 6.4 6.7 
Relevant advances 
Synthetic biology techniques 
Patents 
Three approaches to isobutanol production enhancement have been selected and studied in this 
work: 
 1 - Screening of heterologous enzymes more suitable than those found in the S. cerevisiae 
endogenous Ehrlich pathway along with their overexpression and deletion of PDC-1 [2]. 
 2 -  Re-localization of the whole Ehrlich pathway into the cytosol [3]. 
 3 -  Re-localization of the whole Ehrlich pathway into the mitochondria [4]. 
The table below displays  the results obtained in these experiments. 
 
Companies strive for monopolizing the isobutanol market niche and patent filing is the best 
way to achieve this. Published patents in the recent years for isobutanol production include: 
o Use of a yeast with an endogenous isobutanol pathway (Butalco) [5] or a heterogeneous 
pathway (Butamax) with overexpression of its enzymes [6]. 
o Specific proteins which allow high isobutanol yields, such a bacterial dyhydroxyacid 
dehydratase  (Butamax) [7], a yeast with enhanced expression of a NADP-dependent 
isocitrate dehydrogenase (Toyota Motor Corporation) [8] or a yeast with a transport protein 
(Gevo) [9]. 
o Modified yeasts with reduced amino acid metabolism or with enhanced tolerance towards 
butanol (Butamax) [10]. 
LoxP-Cre recombinase 
Codon optimization 
Methods for overexpression 
Modular vectors 
Modular or multigenic vectors 
enable the insertion of multiple 
gene expression cassettes in 
different orientations into a 
single plasmid. Up to an entire 
metabolic pathway can be 
introduced in the host 
microorganism via a single 
vector. 
This is feasible thanks to unique 
restriction sites which flank all 
expression cassettes. Only a 
“scar” composed by two non-
functional restriction sites is left 
after the insertion. 
Relevant bibliography Conclusions 
o Use of 2μ plasmids is a common method to overexpress 
a gene at a mRNA level. These are shuttle vectors able 
to replicate in both Escherichia coli and S. cerevisiae. 
The 2μ replication origin is responsible for their high 
copy number. 
o Promoters and terminators are often modified in order 
to maximize protein yield. Common promoters include 
PGK1 (phosphoglycerate kinase 1) and ADH1 (alcohol 
dehydrogenase 1). 
When expressing a recombinant gene, the codon usage of 
the strain, which is the relative abundance of tRNA 
isoacceptors, must be taken into account. Thus, codon 
optimization of the gene sequence is common in 
heterologous expression. 
The LoxP/Cre 
recombinase system 
allows the deletion or 
insertion of a gene. Cre is 
a LoxP site-specific 
recombinase. In gene 
deletion, Cre recognises 
and cleaves LoxP sites and 
the ends are rejoined. 
Figure 1. Representation of the reactions comprising the Ehrlich pathway in yeast and the enzymes involved. [1] 
Figure 3. Basic scheme of a 
modular vector in which each 
position represents a different 
cassette. [4] 
Figure 2. Gene deletion in the LoxP-
recombinase system. 
Glucose 
2 x pyruvate 
2-acetolactate 
2-ketoisovalerate 
Glycolysis 
Ilv2 
Ilv5 
Ilv3 
2 x acetaldehyde 2 x ethanol 
PDC 
L-Valine 
2 x CO2 2 NADH 2 NAD+ 
H2O 
CO2 
NADPH 
Bat1 
2,3-dihydroxy-isovalerate 
Table 1.  Values of isobutanol yield, productivity and isobutanol/glucose yield in each of the studied articles. 
The best results are obtained combining synthetic biology techniques with metabolic 
engineering (cases 2 and 3). More specifically, the best results are obtained in case 2. 
Nevertheless, the results might have been better in case 3 if techniques such as codon 
optimization had been used. 
Industrial butanol production is still at its infancy, as there are many question marks 
remaining. 
o Several bottlenecks must be resolved, such as by-product accumulation and 
maintenance of the redox balance. 
o The host would ideally have resistance to isobutanol toxicity and high growth rates 
to prevent contamination . 
o No industrial strains have been tested yet, and glucose is the only carbon source 
tested. 
The ideal approach would be a consolidated bioprocess in which the yeast secretes 
enzymes for lignocellulosic biomass usage as carbon source, as achieved in the case of 
bioethanol. 
Selectable markers 
Common selectable markers include antibiotic resistances 
such as geneticin resistance (kanMX) and auxotrophic 
markers, which include URA3 as shown in figure 3. 
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